Centro de Investigacion Clinica Chapultepec S.A. de C.V.

Morelia 58260

2 studies enrolling now · 6 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Carcinoma, Non-Small-Cell Lung, Crohn's Disease, Diabetes Mellitus, Type 2, Hypertension, Inflammatory Bowel Diseases, Ischemic Stroke; Ischemic Attack, Transient, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension — Completed
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed